Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Artificial Intelligence–Enabled Analysis of Statin-Related Topics and Sentiments on Social Media

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This qualitative study evaluates user-generated, publicly available posts and comments about statin-related topics: ketogenic diets, diabetes, and supplements; statin adverse effects; statin hesitancy; clinical trial appraisals; pharmaceutical industry bias; and red yeast rice.

          Key Points

          Question

          What are public perceptions of statins as expressed on a widely used social media platform?

          Findings

          In this qualitative study of 10 233 unique statin-related discussions, an artificial intelligence (AI) pipeline was developed to analyze these discussions, which were automatically categorized into 100 topics and 6 thematic groups (ketogenic diets, diabetes, supplements, and statins; statin adverse effects; statin hesitancy; clinical trial appraisals; pharmaceutical industry bias and statins; and red yeast rice and statins). Sentiment analysis of these discussions showed that most of them had a neutral or negative sentiment.

          Meaning

          Findings from this study suggest that AI-enabled analysis of large, contemporary social media data may generate insights into public perceptions and help guide strategies for addressing barriers to statin use and adherence.

          Abstract

          Importance

          Despite compelling evidence that statins are safe, are generally well tolerated, and reduce cardiovascular events, statins are underused even in patients with the highest risk. Social media may provide contemporary insights into public perceptions about statins.

          Objective

          To characterize and classify public perceptions about statins that were gleaned from more than a decade of statin-related discussions on Reddit, a widely used social media platform.

          Design, Setting, and Participants

          This qualitative study analyzed all statin-related discussions on the social media platform that were dated between January 1, 2009, and July 12, 2022. Statin- and cholesterol-focused communities, were identified to create a list of statin-related discussions. An artificial intelligence (AI) pipeline was developed to cluster these discussions into specific topics and overarching thematic groups. The pipeline consisted of a semisupervised natural language processing model (BERT [Bidirectional Encoder Representations from Transformers]), a dimensionality reduction technique, and a clustering algorithm. The sentiment for each discussion was labeled as positive, neutral, or negative using a pretrained BERT model.

          Exposures

          Statin-related posts and comments containing the terms statin and cholesterol.

          Main Outcomes and Measures

          Statin-related topics and thematic groups.

          Results

          A total of 10 233 unique statin-related discussions (961 posts and 9272 comments) from 5188 unique authors were identified. The number of statin-related discussions increased by a mean (SD) of 32.9% (41.1%) per year. A total of 100 discussion topics were identified and were classified into 6 overarching thematic groups: (1) ketogenic diets, diabetes, supplements, and statins; (2) statin adverse effects; (3) statin hesitancy; (4) clinical trial appraisals; (5) pharmaceutical industry bias and statins; and (6) red yeast rice and statins. The sentiment analysis revealed that most discussions had a neutral (66.6%) or negative (30.8%) sentiment.

          Conclusions and Relevance

          Results of this study demonstrated the potential of an AI approach to analyze large, contemporary, publicly available social media data and generate insights into public perceptions about statins. This information may help guide strategies for addressing barriers to statin use and adherence.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          Standards for reporting qualitative research: a synthesis of recommendations.

          Standards for reporting exist for many types of quantitative research, but currently none exist for the broad spectrum of qualitative research. The purpose of the present study was to formulate and define standards for reporting qualitative research while preserving the requisite flexibility to accommodate various paradigms, approaches, and methods.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Silhouettes: A graphical aid to the interpretation and validation of cluster analysis

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association

              Background: The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure, and glucose control) that contribute to cardiovascular health. The Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, congenital heart disease, rhythm disorders, subclinical atherosclerosis, coronary heart disease, heart failure, valvular disease, venous disease, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs). Methods: The American Heart Association, through its Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States to provide the most current information available in the annual Statistical Update. The 2022 Statistical Update is the product of a full year’s worth of effort by dedicated volunteer clinicians and scientists, committed government professionals, and American Heart Association staff members. This year’s edition includes data on the monitoring and benefits of cardiovascular health in the population and an enhanced focus on social determinants of health, adverse pregnancy outcomes, vascular contributions to brain health, and the global burden of cardiovascular disease and healthy life expectancy. Results: Each of the chapters in the Statistical Update focuses on a different topic related to heart disease and stroke statistics. Conclusions: The Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.
                Bookmark

                Author and article information

                Journal
                JAMA Netw Open
                JAMA Netw Open
                JAMA Network Open
                American Medical Association
                2574-3805
                24 April 2023
                April 2023
                24 April 2023
                : 6
                : 4
                : e239747
                Affiliations
                [1 ]Department of Medicine, Stanford University, Stanford, California
                [2 ]Department of Information Technology & Digital Innovation, Leiden University Medical Center (LUMC), Leiden, the Netherlands
                [3 ]CAIRELab, LUMC, Leiden, the Netherlands
                [4 ]Department of Biomedical Data Science, Stanford University, Stanford, California
                [5 ]Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
                [6 ]Department of Surgery, Stanford University School of Medicine, Stanford, California
                [7 ]Division of Cardiovascular Medicine and Cardiovascular Institute, Stanford University, Stanford, California
                Author notes
                Article Information
                Accepted for Publication: March 10, 2023.
                Published: April 24, 2023. doi:10.1001/jamanetworkopen.2023.9747
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2023 Somani S et al. JAMA Network Open.
                Corresponding Author: Fatima Rodriguez, MD, MPH, Center for Academic Medicine, Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, 453 Quarry Rd, Mail Code 5687, Palo Alto, CA 94304 ( frodrigu@ 123456stanford.edu ).
                Author Contributions: Drs Somani and Hernandez-Boussard had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Dr Somani and Ms van Buchem contributed equally as co–first authors, and Drs Hernandez-Boussard and Rodriguez contributed equally as co–senior authors.
                Concept and design: All authors.
                Acquisition, analysis, or interpretation of data: All authors.
                Drafting of the manuscript: Somani, van Buchem.
                Critical revision of the manuscript for important intellectual content: All authors.
                Statistical analysis: Somani, van Buchem.
                Obtained funding: Hernandez-Boussard, Rodriguez.
                Administrative, technical, or material support: Somani, Hernandez-Boussard, Rodriguez.
                Supervision: Hernandez-Boussard, Rodriguez.
                Conflict of Interest Disclosures: Dr Rodriguez reported receiving personal fees from HealthPals, Novartis, Novo Nordisk, and AstraZeneca outside the submitted work. No other disclosures were reported.
                Funding/Support: Dr Rodriguez was funded by grant 1K01HL144607 from the National Heart, Lung, and Blood Institute of the National Institutes of Health, a grant from the American Heart Association/Harold Amos Faculty Development Program, and grant 2022051 from the Doris Duke Foundation.
                Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
                Data Sharing Statement: See Supplement 2.
                Article
                zoi230310
                10.1001/jamanetworkopen.2023.9747
                10126874
                37093597
                3b045948-ac36-4530-ba73-d97f26260b45
                Copyright 2023 Somani S et al. JAMA Network Open.

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 7 January 2023
                : 10 March 2023
                Categories
                Research
                Original Investigation
                Online Only
                Cardiology

                Comments

                Comment on this article